Latest News
Global Times: Xi's footprints convey China's contribution, injecting stability to a turbulent world
BEIJING, Jan. 28, 2023 /PRNewswire/ -- The global landscape has, in recent years, gone through profound, complex and turbulent changes since the end of the Cold War. In the eyes of geopolitical observers, the ongoing COVID-19 pandemic, the intensifying geopolitical tensions and the "ripple effect...
2023-01-28 15:40
3972
CNEY Announces Proposed Underwritten Public Offering of Securities
LISHUI, China, Jan. 27, 2023 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY", or the "Company") today announced that it intends to offer its securities in a public offering. All of the securities are being offered by CNEY. In addition, CNEY intends to grant the underwriter in the of...
2023-01-28 06:37
6076
CNEY Reports Its Audited Financial Results for Fiscal Year 2022
LISHUI, China, Jan. 27, 2023 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) today reported to the public its audited annual financial statements for the fiscal year endedSeptember 30, 2022 (FY2022). It is worthwhile to note that, while facing macroeconomic challenges and supply chain uncert...
2023-01-28 06:15
6423
PINTEC Announces Changes to Management and Board of Directors
BEIJING, Jan. 27, 2023 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading independent technology platform enabling financial services inChina, today announced Mr. Zexiong Huang will be its Chief Executive Officer, acting Chief Financial Officer,...
2023-01-28 05:30
6891
WHO Goodwill Ambassador for Leprosy Elimination Has Audience with Pope Francis
Pope Supports Continued Efforts Against Leprosy, Reflects on Tragedy of War TOKYO, Jan. 27, 2023 /PRNewswire/ -- WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa had an audience with His Holiness Pope Francis at the Vatican onJanuary 26, 2023, during which he requested the Pope's su...
2023-01-27 22:00
4655
CNEY Entered the Drinkable Water Market with a Large Order
LISHUI, China, Jan. 27, 2023 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) today announced that its wholly owned subsidiary, Zhejiang CN Energy New Materials Co., Ltd., had recently obtained a first order to supply high-quality wood-based activated carbon directly to a producer of potable ...
2023-01-27 21:30
5014
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs
* SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in theKingdom of Saudi Arabia(KSA) * SK bioscience also explained a new global partnership model aiming to promote public health in deve...
2023-01-27 20:00
5186
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
* Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit ofKRW 312.8 billion. * FY'22 consolidated revenue of KRW 3.00 trillion and FY'22 operating profit ofKRW 983.6 billion. * Strong growth momentum expected to continue with active expansions in capacity, geography, an...
2023-01-27 14:52
4739
LG Energy Solution Posts 2022 Earnings with Record-High Annual Revenue and Operating Profit
* LGES marks KRW 25.6 trillion in consolidated revenue and KRW 1.2 trillion in operating profit in 2022 * 2023 goal set at 25-30 percent increase in annual revenue, with over 50 percent increase in capital expenditure * The company to concentrate on four key initiatives to respond to the ris...
2023-01-27 09:30
4292
MicroCloud Hologram (NASDAQ: HOLO) Announces the Launch of A Holographic Brain-Computer Interface(BCI) Data Acquisition System
BEIJING, Jan. 26, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced the launch of its holographic BCI (Brain-Computer Interface) data acquisition system. The system is the result of the Company's i...
2023-01-26 21:00
3467
Akeso Received First Tranche of US$300 Million Upfront Payment from Summit! Summit Is Accelerating Clinical Development of Ivonescimab
HONG KONG, Jan. 26, 2023 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company"), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced the Hart-Scott-Rodino (HSR) Act filing has c...
2023-01-26 20:24
4698
Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
* Longevity Biomedical is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase health span for the rapidly growing global aging pop...
2023-01-26 19:30
3780
Minviro completes successful capital raise of £2,100,000 and welcomes industry leading investors as new shareholders
Funds raised will be dedicated to helping Minviro expand into key markets, includingAsia, Australia and the Americas, and develop local operational presence to serve a rapidly growing global client base. LONDON, Jan. 26, 2023 /PRNewswire/ -- Minviro is a market leading sustainability consulting ...
2023-01-26 18:00
3186
Global Times: Three years on, Wuhan embraces joyful, bustling Chinese New Year thanks to nation's proactive COVID optimization
BEIJING, Jan. 26, 2023 /PRNewswire/ -- For many local residents in Wuhan, Central China's Hubei Province, which reported the first COVID-19 outbreak in China three years ago, the Chinese New Year in 2020 was an unforgettable one as it coincided the moment when the city imposed a lockdown to cut o...
2023-01-26 17:33
2447
Yum China Announces Disclosure under Hong Kong Stock Exchange Rules in Relation to a Possible Quarterly Dividend
SHANGHAI, Jan. 26, 2023 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced, in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "HKEX") which require advance notice of boa...
2023-01-26 16:30
4255
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane
* First Generic of Abraxane in Korea, World 4th Commercial Scale-Up * Global tech-transfer expected to US, Japan, and Europe SEONGNAM, South Korea ,Jan. 26, 2023 /PRNewswire/ -- SN BioScience (CEO Park Young-hwan) and Boryeong (CEOJang Doo-hyun) signed a domestic manufacturing technology transf...
2023-01-26 14:31
3268
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies
NANJING, China, Jan. 25, 2023 /PRNewswire/ -- As the tissue engineering and regenerative medicine industry has shown tremendous potential in clinical practices in recent years worldwide,China's blue ocean market welcomes the first wave of acquisitions. ReLive Biotechnologies, Ltd. ("ReLive" or "...
2023-01-26 12:11
2865
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax
* Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack * Provides the most potent bactericidal ability that no other PEP antibiotics in the market can exhibit * Further developments are planned to conduct with a licensing/col...
2023-01-26 10:34
2744
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders
CAMBRIDGE, Mass., Jan. 26, 2023 /PRNewswire/ -- HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated byHarbour BioMed (HKEX: 02142), announced that it completed seed financing to advance its leading programs, novel antibody therapies to treat congenital adrenal hype...
2023-01-26 09:22
3968
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies
NANJING, China, Jan. 25, 2023 /PRNewswire/ -- As the tissue engineering and regenerative treatment industry has shown tremendous potential in clinical practices in recent years worldwide,China's blue ocean market welcomes the first wave of acquisitions. ReLive Biotechnologies, Ltd. ("ReLive" or ...
2023-01-26 08:11
3130
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11
Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00
The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
131053
Royal Bank of Canada announces agreement to acquire Yarra Capital Management
2026-11-09 21:00
9200
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
2026-11-09 23:00
8485
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
2026-11-10 22:17
6885
